February 27, 2020 / 1:26 PM / a month ago

BRIEF-Neogenomics Q4 Revenue Rose 40 Percent To $107 Million

Feb 27 (Reuters) - Neogenomics Inc:

* QUARTERLY EARNINGS PER SHARE $0.06

* SEES FY 2020 CONSOLIDATED REVENUE $464 MILLION - $474 MILLION

* SEES FY 2020 ADJUSTED EBITDA $60 MILLION - $65 MILLION

* Q4 EARNINGS PER SHARE VIEW $0.06, REVENUE VIEW $104.2 MILLION — REFINITIV IBES DATA

* QUARTERLY ADJUSTED EARNINGS PER SHARE $0.10 Source text: (bit.ly/2vc35qz) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below